341 related articles for article (PubMed ID: 21400026)
21. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
22. Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study.
El-Rashedy FH; Ragab SM; Dawood AA; Temraz SA
Indian J Med Paediatr Oncol; 2015; 36(4):265-70. PubMed ID: 26811598
[TBL] [Abstract][Full Text] [Related]
23. [Relationships between thiopurine methyltransferase gene polymorphisms and its enzymatic activity].
Ma XL; Wu MY; Hu YM; Zu P; Li ZG
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):456-9. PubMed ID: 17152495
[TBL] [Abstract][Full Text] [Related]
24. [Significance of TPMT activity and TGNs level detection for individualizing 6-mercaptopurine chemotherapy].
Gu LJ; Ye QD; Liang AB; Zhao JC; Xue HL; Tang YN; Chen J; Ye YC
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):18-21. PubMed ID: 12679004
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
[TBL] [Abstract][Full Text] [Related]
26. [Importance of genotyping of thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy].
Dokmanović L; Janić D; Krstovski N; Zukić B; Tosić N; Pavlović S
Srp Arh Celok Lek; 2008; 136(11-12):609-16. PubMed ID: 19177822
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.
Stocco G; Crews KR; Evans WE
Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.
Jiménez-Morales S; Ramírez-Florencio M; Mejía-Aranguré JM; Núñez-Enríquez JC; Bekker-Mendez C; Torres-Escalante JL; Flores-Lujano J; Jiménez-Hernández E; Del Carmen Rodríguez-Zepeda M; Leal YA; González-Montalvo PM; Pantoja-Guillen F; Peñaloza-Gonzalez JG; Gutiérrez-Juárez EI; Núñez-Villegas NN; Pérez-Saldivar ML; Guerra-Castillo FX; Flores-Villegas LV; Ramos-Cervantes MT; Fragoso JM; García-Escalante MG; Del Carmen Pinto-Escalante D; Ramírez-Bello J; Hidalgo-Miranda A
Arch Med Res; 2016 Nov; 47(8):615-622. PubMed ID: 28476189
[TBL] [Abstract][Full Text] [Related]
29. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia.
Kham SK; Tan PL; Tay AH; Heng CK; Yeoh AE; Quah TC
J Pediatr Hematol Oncol; 2002; 24(5):353-9. PubMed ID: 12142782
[TBL] [Abstract][Full Text] [Related]
30. Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
Tantawy AAG; Ebeid FSE; Adly AAM; El-Ghoroury E; Mostafa M
J Genet; 2017 Dec; 96(6):905-910. PubMed ID: 29321348
[TBL] [Abstract][Full Text] [Related]
31. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine.
Desire S; Balasubramanian P; Bajel A; George B; Viswabandya A; Mathews V; Srivastava A; Chandy M
Med Oncol; 2010 Dec; 27(4):1046-9. PubMed ID: 19830600
[TBL] [Abstract][Full Text] [Related]
32. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
33. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
[TBL] [Abstract][Full Text] [Related]
34. [Thiopurine S-methyltransferase gene sequence analysis of ALL children severely intolerant to 6-mercaptopurine].
Ma XL; Li WJ; Zheng J; Wang B; Jin M; Zhang DW; Li ZG; Zhang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):876-9. PubMed ID: 22931646
[TBL] [Abstract][Full Text] [Related]
35. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
36. Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia.
Naushad SM; Dorababu P; Rupasree Y; Pavani A; Raghunadharao D; Hussain T; Alrokayan SA; Kutala VK
Cancer Chemother Pharmacol; 2019 May; 83(5):875-880. PubMed ID: 30806759
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
Hawwa AF; Collier PS; Millership JS; McCarthy A; Dempsey S; Cairns C; McElnay JC
Br J Clin Pharmacol; 2008 Dec; 66(6):826-37. PubMed ID: 18823306
[TBL] [Abstract][Full Text] [Related]
38. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.
Dorababu P; Nagesh N; Linga VG; Gundeti S; Kutala VK; Reddanna P; Digumarti R
Eur J Clin Pharmacol; 2012 Apr; 68(4):379-87. PubMed ID: 22009189
[TBL] [Abstract][Full Text] [Related]
39. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.
Lennard L; Cartwright CS; Wade R; Vora A
Br J Haematol; 2015 Apr; 169(2):228-40. PubMed ID: 25441457
[TBL] [Abstract][Full Text] [Related]
40. [Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].
Hao QS; Wang Z; Fang QY; Gong XY; Liu KQ; Li Y; Wei H; Wang Y; Li QH; Wang M; Tian Z; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):911-916. PubMed ID: 35045652
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
